INCOME STATEMENT
Jubilant Pharmova Ltd.
BSE
Jun 06
1139.60
-1.50 ( -0.13%)
Volume
2439
Prev. Close
1141.10
Open Price
1142.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
1140.00
-2.30 ( -0.20%)
Volume
116793
Prev. Close
1142.30
Open Price
1142.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE700A01033
|
Market Cap. ( ₹ in Cr. )
|
18158.05
|
P/BV
|
3.06
|
Book Value ( ₹ )
|
372.96
|
BSE Code
|
530019
|
52 Week High/Low ( ₹ )
|
1310/693
|
FV/ML
|
1/1
|
P/E(X)
|
21.63
|
NSE Code
|
JUBLPHARMAEQ
|
Book Closure
|
25/07/2025
|
EPS ( ₹ )
|
52.70
|
Div Yield (%)
|
0.44
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 734.00 | 755.20 | 774.42 | 87.75 | 2688.07 |
Other Operating Revenues | 11.70 | 29.50 | 35.70 | 0.00 | 21.43 |
Total Operating Revenues | 745.70 | 784.70 | 810.12 | 87.75 | 2709.50 |
| | | | | |
Other Income | 99.60 | 103.40 | 137.89 | 125.87 | 47.88 |
Total Revenue | 845.30 | 888.10 | 948.01 | 213.62 | 2757.38 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 282.50 | 310.00 | 396.30 | 0.00 | 1328.92 |
Purchase Of Stock-In Trade | 0.00 | 6.50 | 14.81 | 0.00 | 66.23 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -6.70 | 39.00 | 3.45 | 0.00 | 55.21 |
Employee Benefit Expenses | 203.00 | 190.00 | 167.27 | 49.21 | 220.67 |
Finance Costs | 29.80 | 29.90 | 18.52 | 30.59 | 101.80 |
Depreciation And Amortisation Expenses | 53.10 | 48.30 | 43.25 | 6.25 | 99.97 |
Other Expenses | 234.80 | 222.70 | 225.07 | 45.32 | 611.41 |
Total Expenses | 796.50 | 846.40 | 868.67 | 131.37 | 2484.21 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 48.80 | 41.70 | 79.34 | 82.25 | 273.17 |
| | | | | |
Exceptional Items | -11.20 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 37.60 | 41.70 | 79.34 | 82.25 | 273.17 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 18.40 | 6.80 | 13.82 | 13.66 | 45.44 |
Deferred Tax | 0.00 | 3.30 | 15.64 | -9.91 | 13.25 |
Total Tax Expenses | 18.40 | 10.10 | 29.46 | 3.75 | 58.69 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 19.20 | 31.60 | 49.88 | 78.50 | 214.48 |
| | | | | |
Profit/Loss From Continuing Operations | 19.20 | 31.60 | 49.88 | 78.50 | 214.48 |
| | | | | |
Profit/Loss For The Period | 19.20 | 31.60 | 49.88 | 78.50 | 214.48 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 1.21 | 1.99 | 3.13 | 4.93 | 13.47 |
Diluted EPS (Rs.) | 1.21 | 1.99 | 3.13 | 4.93 | 13.47 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 79.60 | 79.64 | 79.64 | 0.00 |
Equity Dividend Rate (%) | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |